title: Effects of dalfampridine on attacks in patients with episodic ataxia type 2: an observational study.
authors.forename: Jens
authors.initials: J
authors.lastname: Claassen
authors.forename: Julian
authors.initials: J
authors.lastname: Teufel
authors.forename: Roger
authors.initials: R
authors.lastname: Kalla
authors.forename: Rainer
authors.initials: R
authors.lastname: Spiegel
authors.forename: Michael
authors.initials: M
authors.lastname: Strupp
mesh_terms: D015761:4-Aminopyridine / Q000627:therapeutic use*; D000328:Adult; D001259:Ataxia / Q000188:drug therapy* / Q000235:genetics; D015220:Calcium Channels / Q000235:genetics; D006801:Humans; D008297:Male; D008875:Middle Aged; D009759:Nystagmus, Pathologic / Q000188:drug therapy* / Q000235:genetics; D019370:Observation; D026902:Potassium Channel Blockers / Q000627:therapeutic use*; D020864:Calcium Channels, N-Type
chemical_list: D015761:4-Aminopyridine; D015220:Calcium Channels; D026902:Potassium Channel Blockers; C105656:CACNA1A protein, human; D020864:Calcium Channels, N-Type